6. Henry Schein ( HSIC) distributes health care products and services to health care practitioners, government and other institutions. It serves in two segments: health care distribution and technology. HSIC will announce third-quarter results on Nov. 1.

Net income for the third quarter of 2011 is estimated at $93.86 billion, or $1.01 per share, compared to $87.89 million, or 94 cents per share, in the year-ago quarter. Sales are forecast at $2.07 billion, up 9% from $1.89 billion in the third quarter of 2010. Gross margin for the quarter is seen increasing to 28.70% from 28.38% in the year-earlier quarter. Cash flow per share is seen at $1.36, compared to 53 cents in 2010 third quarter.

Of the 16 analysts covering the stock, 50% recommend a buy and 44% suggest a hold. Analysts polled by Bloomberg expect the stock to gain an average 8.6% to $75.64 from current levels over the next 12 months.

If you liked this article you might like

The 6 Medications Being Used to Tackle the Opioid Epidemic

Dow, S&P 500 Set New Records as Fed Moves to Unwind Balance Sheet

Stocks In Negative Territory as Chances for December Hike Surge

The Wait for 'Milestone' Fed Meeting Keeps Stocks in Flux